Advantages of Hyperbaric Oxygen Treatment for Type 2 Diabetes Mellitus in Mice: Involvement of Leptin
Journal of Diabetes Research · 2025
DOI: 10.1155/jdr/3808140 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Diabetes Research, 2025. Verfasst von Zhounan Zhu und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Pancreatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Leptin, Hyperbaric Oxygenation, Diabetes Mellitus, Experimental. Die Arbeit nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Science and Technology Commission of Shanghai Municipality, Shanghai Municipal Health Commission.
Themen: Diabetes mellitus
Abstract (Originalsprache)
Background
Hyperbaric oxygen treatment (HBOT) is clinically used to improve oxygen supply to hypoperfused tissues under certain conditions. HBOT can decrease the incidence of autoimmune diabetes in nonobese diabetic mice by reducing apoptosis and increasing β ‐cell proliferation. HBOT ameliorates glucose tolerance in Type 2 diabetes (T2D) mellitus patients, but the underlying mechanism needs further investigation.
Methods
We used a diet‐induced T2D mouse model and a genetic mouse model (ob/ob mice) to evaluate the effects of HBOT on serum glucose levels in mice. The body weights and blood glucose levels of the mice were measured weekly. An oral glucose tolerance test (OGTT) was performed 12 weeks after the start of the experiment. All the mice were euthanized, and the serum and liver tissues were collected to test the total cholesterol, triglycerides, alanine aminotransferase, aspartate aminotransferase, malondialdehyde, and antioxidant enzymes.
Results
Our results demonstrated that HBOT can delay/attenuate the onset of diet‐associated T2D in wild‐type mice. However, HBOT had no significant effects on blood glucose or T2D incidence in ob/ob mice. Furthermore, we found that HBOT improved glucose tolerance and liver steatosis in diet‐induced T2D model mice but not in ob/ob mice. Our results indicated that the effects of HBOT on T2D were dependent at least partly on the presence of leptin.
Conclusion
Our study offers a rationale for using serum leptin as a predictor of clinical outcomes of HBOT and elucidates possible reasons why many patients may experience HBOT failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary Pancreatic Surgery, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China.
- Department of Hyperbaric Oxygen Treatment, First Affiliated Hospital of Naval Military Medical University, Shanghai, China.
- Clinical Research Institute, Third Affiliated Hospital of Naval Military Medical University, Shanghai, China.
ORCID-Profile: Zhounan Zhu, Wanyin Wang, Chenggang Zheng, Qinghe Tang
Förderung
- Science and Technology Commission of Shanghai Municipality
- Shanghai Municipal Health Commission
Zitieren
APA
Zhu, Z., Zhang, B., Wang, W., Yi, H., Zheng, C., & Tang, Q. (2025). Advantages of Hyperbaric Oxygen Treatment for Type 2 Diabetes Mellitus in Mice: Involvement of Leptin. Journal of Diabetes Research. https://doi.org/10.1155/jdr/3808140
Vancouver
Zhu Z, Zhang B, Wang W, Yi H, Zheng C, Tang Q. Advantages of Hyperbaric Oxygen Treatment for Type 2 Diabetes Mellitus in Mice: Involvement of Leptin. Journal of Diabetes Research. 2025. doi:10.1155/jdr/3808140
BibTeX
@article{Zhu2025,
author = {Zhu, Zhounan and Zhang, Bin and Wang, Wanyin and Yi, Hongjie and Zheng, Chenggang and Tang, Qinghe},
title = {Advantages of Hyperbaric Oxygen Treatment for Type 2 Diabetes Mellitus in Mice: Involvement of Leptin},
journal = {Journal of Diabetes Research},
year = {2025},
doi = {10.1155/jdr/3808140}
}
EUVIMED